Home › Funds › Imprint Wealth LLC › IMMX
Imprint Wealth LLC position in IMMX
IMMIX BIOPHARMA INC · Health Care
Imprint Wealth LLC reported holding 20,938 shares of IMMX (IMMIX BIOPHARMA INC) in its Q3 2026 13F filing — a position valued at US$218K, representing 0.79% of its reported portfolio and ranking #28 among its reported holdings. Imprint Wealth LLC has disclosed IMMX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Imprint Wealth LLC's IMMX position evolved
Imprint Wealth LLC first disclosed a stake in IMMX in Q3 2025 at 67,423 shares (US$141K). The position peaked in Q1 2026 at 31,248 shares, worth US$285K. Across 5 filings, Imprint Wealth LLC increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 20,938 shares valued at US$218K — a reduction of -5,295 shares quarter over quarter.. Notable position changes include a 70% trim in Q4 2025 (shares rose 74% over the following quarter), a 56% increase in Q1 2026 (shares rose 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 67.42K | $140.91K | New |
| Q4 2025 | 20.01K | $104.65K | Reduce |
| Q1 2026 | 31.25K | $284.67K | Add |
| Q2 2026 | 26.23K | $270.46K | Reduce |
| Q3 2026 | 20.94K | $217.86K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMMX and 13F data
IMMX (IMMIX BIOPHARMA INC) is a Health Care company. 93 other funds we track also report a position in IMMX — the largest reported positions include EVENTIDE ASSET MANAGEMENT, LLC (US$54.0M), Saturn V Capital Management LP (US$48.5M), Opaleye Management Inc. (US$24.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMMX
- EVENTIDE ASSET MANAGEMENT, LLC 5.19M sh · $53.97M · Q3 2026
- Saturn V Capital Management LP 4.66M sh · $48.50M · Q3 2026
- Opaleye Management Inc. 2.35M sh · $24.18M · Q2 2026
- GREAT POINT PARTNERS LLC 1.28M sh · $13.17M · Q2 2026
- Velan Capital Investment Management LP 1.08M sh · $11.29M · Q3 2026
- Bleichroeder LP 1.00M sh · $10.40M · Q3 2026
- Blue Owl Capital Holdings LP 602.05K sh · $6.26M · Q3 2026
- Monashee Investment Management LLC 450.00K sh · $4.68M · Q3 2026
- KVP Capital Advisors, LP 230.42K sh · $2.40M · Q3 2026
More on Imprint Wealth LLC
FAQ
How long has Imprint Wealth LLC held IMMX?
Imprint Wealth LLC has disclosed IMMX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is Imprint Wealth LLC's current position in IMMX?
As of Q3 2026, Imprint Wealth LLC holds 20.94K shares of IMMX (IMMIX BIOPHARMA INC), valued at $217.86K, representing 0.79% of its reported portfolio and ranking #28.
Has Imprint Wealth LLC been buying or selling IMMX?
In the latest 13F filing (Q3 2026), Imprint Wealth LLC reduced its position in IMMX. The position peaked in Q1 2026 at 31.25K shares.
Which other funds hold IMMX?
Other major institutional holders of IMMX include EVENTIDE ASSET MANAGEMENT, LLC, Saturn V Capital Management LP, Opaleye Management Inc., among 93 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.